Cellebrite Di LTD Form 4 insider transactions

Ryusuke Utsumi, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.

Yonatan Domnitz, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.

Adam Clammer, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.

Buren Brandon Van, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.

Troy Richardson, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.

Dafna Gruber, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.

Nadine Baudot-Trajtenberg, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.

Thomas E. Hogan, Advisor of Cellebrite DI Ltd., sold 25,299 shares of common stock on August 25, 2026 for $11.29 per share.

David Nicholas Gee, Chief Marketing Officer of Cellebrite DI Ltd., sold 4,323 shares of common stock on August 24, 2026 for $11.36 per share.

Marcus Jewell, Global Chief Revenue Officer of Cellebrite DI Ltd., sold 12,562 shares of common stock on August 21, 2026 for $11.24 per share.

David Nicholas Gee, Chief Marketing Officer of Cellebrite DI Ltd., sold 2,198 shares of common stock on August 21, 2026 for $11.24 per share.

Thomas E. Hogan, Chief Executive Officer and a Director of Cellebrite DI Ltd., sold 139,713 shares of common stock on August 11, 2026 for $15.39 per share.

Marcus Jewell, Global Chief Revenue Officer of Cellebrite DI Ltd., sold 411 shares of common stock on August 12, 2026 for $16.07 per share.

David Nicholas Gee, Chief Marketing Officer of Cellebrite DI Ltd., sold 230 shares of common stock on August 12, 2026 for $16.07 per share.

Cellebrite's Chief Financial Officer, David Barter, disposed of 41,734 ordinary shares to cover tax obligations related to vested restricted stock units.

Cellebrite CEO Thomas E. Hogan reported the sale of 103,188 ordinary shares to cover tax withholding obligations related to the vesting of restricted stock units.

Cellebrite Chief Marketing Officer David Gee sold company shares to cover tax liabilities related to vested restricted stock units, as disclosed in a Form 4 filing.

Cellebrite's Global Chief Revenue Officer, Marcus Jewell, reported the disposition of 12,658 ordinary shares to cover tax withholding obligations related to vested restricted stock units.

Cellebrite's Chief Marketing Officer, David Gee, reported the sale of 228 ordinary shares to cover tax obligations related to vested restricted stock units.